(Reuters) -Germany's chemical industry association said on Wednesday that production, sales, and prices in the sector declined in the second quarter, citing uncertainties regarding the U.S. tariff
Germany's Chemical Industry Sees Lowest Capacity Utilization in 30 Years
Current State of Germany's Chemical Industry
(Reuters) -Germany's chemical industry association on Wednesday said its capacity utilization hit its lowest level in more than 30 years in the second quarter as sales and prices declined on uncertainties around U.S. tariffs.
Capacity Utilization and Production Trends
In the April-June period, Germany's chemical industry was running at only 72% of its full production capacity, the lowest level since 1991, and well below the level required to break even, VCI said.
Impact of U.S. Tariffs on Exports
The VCI association said pull-forward effects in business with the United States waned throughout the April-June period, as exports had been brought forward in anticipation of tariffs on goods from Europe.
Annual Production Comparisons
European chemical manufacturers are grappling with renewed challenges as U.S. tariffs disrupt global trade, leading customers to postpone purchases and weakening demand in a sector still recovering from the 2022 energy crisis.
Overall production in Germany's chemicals sector including pharmaceuticals fell 3.8% quarter-on-quarter, contrasting with the January-March quarterly increase of 6.7%.
"Weak demand, declining sales, and production far below pre-crisis levels - this is the current reality in our industry and also in large parts of German industry," VCI managing director Wolfgang Grosse Entrup said in a statement.
The sector, the third-largest industry in Europe's economic powerhouse Germany, can be seen as a bellwether for the broader economy as it produces materials used in sectors ranging from automotive and construction to agriculture and textiles.
Pharmaceutical output fell by 5.6% compared with the previous quarter.
On an annual comparison, overall quarterly production was down 3.1%, or 5.1% when pharmaceuticals were excluded, and revenue fell by 2.7% compared with the same period last year.
The industry maintained its 2025 guidance for production volumes including pharmaceuticals to fall by 2% and industrial sales by 1%.
(Reporting by Bartosz Dabrowski and Cian Muenster in Gdansk)
